These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 32859169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia.
    Leblebjian H, DeAngelo DJ, Skirvin JA, Stone RM, Wadleigh M, Werner L, Neuberg DS, Bartel S, McDonnell AM.
    Leuk Res; 2013 Jul; 37(7):747-51. PubMed ID: 23643326
    [Abstract] [Full Text] [Related]

  • 3. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
    Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L.
    Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recurrent differentiation syndrome or septic shock? Unresolved dilemma in a patient with acute promyelocytic leukemia.
    Jeddi R, Ghédira H, Amor RB, Menif S, Belhadjali Z, Meddeb B.
    Med Oncol; 2011 Mar; 28(1):279-81. PubMed ID: 20204541
    [Abstract] [Full Text] [Related]

  • 6. Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".
    Nakamaki T, Hino K, Yokoyama A, Hisatake J, Tomoyasu S, Honma Y, Hozumi M, Tsuruoka N.
    Anticancer Res; 1994 Mar; 14(3A):817-23. PubMed ID: 7521152
    [Abstract] [Full Text] [Related]

  • 7. [Expression and significance of interleukin 6, interleukin 8 and their receptors in acute promyelocytic leukemia during all-trans retinoic acid induction treatment].
    Zeng H, Zhang X, Chen Z.
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):357-60. PubMed ID: 10921031
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia.
    Mohammadzadeh Z, Omidkhoda A, Chahardouli B, Hoseinzadeh G, Moghaddam KA, Mousavi SA, Rostami S.
    BMC Cancer; 2021 Jan 09; 21(1):46. PubMed ID: 33422029
    [Abstract] [Full Text] [Related]

  • 10. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia.
    Dore AI, Santana-Lemos BA, Coser VM, Santos FL, Dalmazzo LF, Lima AS, Jacomo RH, Elias J, Falcão RP, Pereira WV, Rego EM.
    J Leukoc Biol; 2007 Nov 09; 82(5):1340-3. PubMed ID: 17704297
    [Abstract] [Full Text] [Related]

  • 11. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
    De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Condé E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P.
    Blood; 1998 Oct 15; 92(8):2712-8. PubMed ID: 9763554
    [Abstract] [Full Text] [Related]

  • 12. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E.
    Leukemia; 1994 Oct 15; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [Abstract] [Full Text] [Related]

  • 13. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
    Montesinos P, Bergua JM, Vellenga E, Rayón C, Parody R, de la Serna J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA.
    Blood; 2009 Jan 22; 113(4):775-83. PubMed ID: 18945964
    [Abstract] [Full Text] [Related]

  • 14. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
    Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.
    Cancer Chemother Pharmacol; 2001 Aug 22; 48 Suppl 1():S65-71. PubMed ID: 11587370
    [Abstract] [Full Text] [Related]

  • 15. HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells.
    Tang L, Chai W, Ye F, Yu Y, Cao L, Yang M, Xie M, Yang L.
    Oncotarget; 2017 Apr 18; 8(16):27314-27327. PubMed ID: 28404891
    [Abstract] [Full Text] [Related]

  • 16. In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome.
    Kojima S, Nishioka C, Chi S, Yokoyama A, Ikezoe T.
    Leuk Res; 2017 Dec 18; 63():1-9. PubMed ID: 29055789
    [Abstract] [Full Text] [Related]

  • 17. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
    Di Micco L, Mirenghi F, Morelli E, De Simone E.
    G Ital Nefrol; 2019 Jul 24; 36(4):. PubMed ID: 31373469
    [Abstract] [Full Text] [Related]

  • 18. Bilateral osteonecrosis of the head of the femur during treatment with retinoic acid in a young patient with acute promyelocytic leukemia.
    Sakakura M, Nishii K, Usui E, Monma F, Tsukada T, Shiku H.
    Int J Hematol; 2006 Apr 24; 83(3):252-3. PubMed ID: 16720557
    [Abstract] [Full Text] [Related]

  • 19. Role of interleukin-8 and growth-regulated oncogene-alpha in the chemotactic migration of all-trans retinoic acid-treated promyelocytic leukemic cells toward alveolar epithelial cells.
    Tsai WH, Hsu HC, Lin CC, Ho CK, Kou YR.
    Crit Care Med; 2007 Mar 24; 35(3):879-85. PubMed ID: 17235257
    [Abstract] [Full Text] [Related]

  • 20. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia.
    Paydas S, Yavuz S, Disel U, Sahin B, Canbolat T, Tuncer I.
    Leuk Lymphoma; 2003 Mar 24; 44(3):547-8. PubMed ID: 12688331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.